HighTower Advisors »

Immunome shares owned by HighTower Advisors

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $180k 17k 10.70
2023-09-30 $157k 19k 8.34
2023-06-30 $126k 16k 7.97
2023-03-31 $83k 17k 4.94

More positions owned by HighTower Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
NVIDIA Corporation (NVDA)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Visa Com Cl A (V)

View all positions for HighTower Advisors

Top funds holding Immunome

Redmile Group
FMR
EcoR1 Capital
T. Rowe Price Associates
Vanguard Group
Point72 Asset Management
Henderson Group
T. Rowe Price Investment Management
Woodline Partners
Avidity Partners Management
BlackRock
Tang Capital Management
Brown Advisory Holdings Incorporated
Sofinnova Ventures
Farallon Capital Management

View all funds holding Immunome